CareDx Reports Second Quarter 2022 Results
CareDx, Inc. (CDNA)
Last caredx, inc. earnings: 4/30 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investors.caredxinc.com
Company Research
Source: Business Wire
BRISBANE, Calif.--(BUSINESS WIRE)--CareDx, Inc. (Nasdaq: CDNA) — The Transplant Company™ focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers -- today reported financial results for the second quarter ended June 30, 2022.Recent Highlights:Delivered 45,000 patient test results, representing growth of 21% compared to second quarter of 2021Achieved revenue of $80.6 million, increasing 9% year-over-yearSustained strong overall GAAP gross margin of 66%Project to achieve profitable growth with positive adjusted EBITDA by first half of 2023Strong capital position with $306M cash, cash equivalents, marketable securities, and no debtRevised 2022 revenue expectations to the range of $325 million to $335 million due to higher than expected mix of commercial patients from the success of new launches and market expansion"We ended the first half of 2022 in an excellent financial position
Show less
Read more
Impact Snapshot
Event Time:
CDNA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CDNA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CDNA alerts
High impacting CareDx, Inc. news events
Weekly update
A roundup of the hottest topics
CDNA
News
- CareDx Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) [Yahoo! Finance]Yahoo! Finance
- CareDx Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)Business Wire
- CareDx, Inc (NASDAQ: CDNA) was upgraded by analysts at Craig Hallum from a "hold" rating to a "buy" rating. They now have a $15.00 price target on the stock.MarketBeat
- CareDx to Report First Quarter 2024 Financial Results [Yahoo! Finance]Yahoo! Finance
- CareDx to Report First Quarter 2024 Financial ResultsBusiness Wire
CDNA
Earnings
- 2/28/24 - Beat
CDNA
Sec Filings
- 5/3/24 - Form 4
- 5/3/24 - Form 3
- 5/3/24 - Form 4
- CDNA's page on the SEC website